Novel Targeted Aptamer-superparamagnetic Iron Oxide Nanoparticle Bioconjugates for Combined Prostate Cancer Imaging and Therapy

2007 ◽  
Vol 69 (3) ◽  
pp. S110-S111 ◽  
Author(s):  
A.Z. Wang ◽  
V. Bagalkot ◽  
F. Gu ◽  
F. Alexis ◽  
C. Vasilliou ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Iron Oxide ◽  
Cancer Imaging ◽  
Superparamagnetic Iron Oxide ◽  
Iron Oxide Nanoparticle ◽  
Oxide Nanoparticle ◽  
Superparamagnetic Iron Oxide Nanoparticle

scholarly journals Superparamagnetic Iron Oxide Nanoparticle-Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy

ChemMedChem ◽  
2008 ◽  
Vol 3 (9) ◽  
pp. 1311-1315 ◽  
Author(s):  
Andrew Z. Wang ◽  
Vaishali Bagalkot ◽  
Christophoros C. Vasilliou ◽  
Frank Gu ◽  
Frank Alexis ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Iron Oxide ◽  
Cancer Imaging ◽  
Superparamagnetic Iron Oxide ◽  
Iron Oxide Nanoparticle ◽  
Oxide Nanoparticle ◽  
Superparamagnetic Iron Oxide Nanoparticle

Succinylated heparin monolayer coating vastly increases superparamagnetic iron oxide nanoparticle T2 proton relaxivity

Nanoscale ◽  
2019 ◽  
Vol 11 (27) ◽  
pp. 12905-12914 ◽  
Author(s):  
Manman Xie ◽  
Shijia Liu ◽  
Christopher J. Butch ◽  
Shaowei Liu ◽  
Ziyang Wang ◽  
...  
Keyword(s):  
Iron Oxide ◽  
Contrast Agents ◽  
Iron Oxide Nanoparticles ◽  
Superparamagnetic Iron Oxide ◽  
Iron Oxide Nanoparticle ◽  
Oxide Nanoparticles ◽  
Clinical Use ◽  
History Of ◽  
Oxide Nanoparticle ◽  
Superparamagnetic Iron Oxide Nanoparticle

Superparamagnetic iron oxide nanoparticles (SPIONs) have a history of clinical use as contrast agents in T2 weighted MRI, though relatively low T2 relaxivity has caused them to fall out of favor as new faster MRI techniques have gained prominence.

Sign in / Sign up

Export Citation Format

Share Document